LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
MUNICH–(BUSINESS WIRE)–Isarna Presents First Interim Phase I Data for ISTH0036 in Advanced Glaucoma at ARVO 2016 Annual Conference
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ocular Hypertension Global Clinical Trials Review, H1, 2016” clinical trials to their offering. The clinical trial report, Ocular Hypertension Global Clinical Trials Revie…
STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB today reported its results for the first quarter 2016. The Group showed stable growth and a step toward consumer markets through the launch of the world’s first gaming notebook with eye tracking. January – March · The Group’s sales totaled SEK 252 million (229), an increase of 10%. Adjusted for currency effects, the increase was 9%. · Gross margin was 73% (74%). · The Group’s operating loss amounted to SEK -17 million (-8). · The combined op
SEATTLE–(BUSINESS WIRE)–Heute wurden neue Ergebnisse der Distance of Choroid Study (DOCS-Studie) der Salutaris Medical Devices, Inc. (SalutarisMD®) zu feuchter AMD (altersabhängige Makuladegeneration) im Rahmen von zwei Präsentationen auf der Jahresversammlung der Association for Research in Vision and Ophthalmology, Inc. (ARVO) präsentiert. Das erste wissenschaftliche Poster von Dr. Kamaljit Balaggan präsentierte klinische Ergebnisse, die über eine geplante interventionelle Studie informiere
SEATTLE–(BUSINESS WIRE)–Today results from the Salutaris Medical Devices, Inc. (SalutarisMD®) wet age-related Macular Degeneration (wet AMD) Distance of Choroid Study (DOCS) were featured in two presentations at the Association for Research in Vision and Ophthalmology, Inc. (ARVO) Annual Meeting. The first poster, by Dr. Kamaljit Balaggan, presented clinical results informing an upcoming interventional study employing the SalutarisMD® novel episcleral brachytherapy device for treatment of wet